25 May 2013
Keywords: submits, nda, azimilide, usa, procter, gamble, submitted
Article | 14 December 1998
Procter & Gamble has submitted a New Drug Application to the US Food andDrug Administration for its antiarrhythmic, azimilide.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.